Drug and Therapeutics Bulletin 1999;37:17-18; doi:10.1136/dtb.1999.37317
Copyright © 1999 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Any place for depot triamcinolone in hay fever?

Relevant BNF section: 6.3.2

The prevalence of hay fever (seasonal allergic rhinitis) in the UK has been increasing; for instance, it doubled from 10 to 20 per 1000 people between the 1970s and 1980s.¹ For a few patients with severe hay fever symptoms, it sometimes helps to give a systemic corticosteroid; one possible option is the injection of a long-acting corticosteroid, such as triamcinolone. We have previously concluded that systemic corticosteroids have only a limited role, that is, when complete control of severe symptoms is judged essential (e.g. for a wedding or exam).² Here we reconsider the case for depot triamcinolone injections in the management of hay fever.

This article has been cited by other articles:

				S M S Nasser and P W Ewan Lesson of the week: Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips BMJ, June 30, 2001; 322(7302): 1589 - 1591. [Full Text] [PDF]